Compile Data Set for Download or QSAR
Report error Found 218 Enz. Inhib. hit(s) with all data for entry = 10130
TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515380BDBM515380(US11098061, Compound I-3)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515381BDBM515381(US11098061, Compound I-4)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515384BDBM515384(US11098061, Compound I-7)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515385BDBM515385(US11098061, Compound I-9)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515386BDBM515386(US11098061, Compound I-10)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515387BDBM515387(US11098061, Compound I-23)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515389BDBM515389(US11098061, Compound II-1)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515389BDBM515389(US11098061, Compound II-1)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515379BDBM515379(US11098061, Compound I-8)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515399BDBM515399(US11098061, Compound II-11)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515399BDBM515399(US11098061, Compound II-11)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515400BDBM515400(US11098061, Compound II-12)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515401BDBM515401(US11098061, Compound II-13)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515402BDBM515402(US11098061, Compound II-14)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515402BDBM515402(US11098061, Compound II-14)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515403BDBM515403(US11098061, Compound II-15)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515403BDBM515403(US11098061, Compound II-15)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515404BDBM515404(US11098061, Compound II-16)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515404BDBM515404(US11098061, Compound II-16)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515405BDBM515405(US11098061, Compound II-19 | US11098061, Compound ...)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515406BDBM515406(US11098061, Compound II-18)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515405BDBM515405(US11098061, Compound II-19 | US11098061, Compound ...)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515390BDBM515390(US11098061, Compound II-2)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515390BDBM515390(US11098061, Compound II-2)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515391BDBM515391(US11098061, Compound II-3)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515391BDBM515391(US11098061, Compound II-3)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515392BDBM515392(US11098061, Compound II-4)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515392BDBM515392(US11098061, Compound II-4)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515393BDBM515393(US11098061, Compound II-5)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515393BDBM515393(US11098061, Compound II-5)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515394BDBM515394(US11098061, Compound II-6)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515394BDBM515394(US11098061, Compound II-6)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515396BDBM515396(US11098061, Compound II-8)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515396BDBM515396(US11098061, Compound II-8)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515397BDBM515397(US11098061, Compound II-9)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515398BDBM515398(US11098061, Compound II-10)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515419BDBM515419(US11098061, Compound III-3)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515420BDBM515420(US11098061, Compound III-4)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515420BDBM515420(US11098061, Compound III-4)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515421BDBM515421(US11098061, Compound III-5)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515422BDBM515422(US11098061, Compound III-6)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515422BDBM515422(US11098061, Compound III-6)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515423BDBM515423(US11098061, Compound III-7)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515424BDBM515424(US11098061, Compound III-8)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515427BDBM515427(US11098061, Compound III-11)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515427BDBM515427(US11098061, Compound III-11)
Affinity DataEC50: <100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515408BDBM515408(US11098061, Compound II-20)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515409BDBM515409(US11098061, Compound II-21)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515410BDBM515410(US11098061, Compound II-22)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 515411BDBM515411(US11098061, Compound II-23)
Affinity DataIC50: 100nMAssay Description:Briefly, a 1.25× stock of MK-2 enzyme from Invitrogen (PV3317), a 5× stock of ATP (AS001A), and ST3-Sox peptide substrate (KNZ1031C) were prepared in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

Displayed 1 to 50 (of 218 total ) | Next | Last >>
Jump to: